விநியோகி ஜான்சன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from PR Newswire. The AP news staff was not involved in its creation. Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization March 12, 2021 GMT (PRNewsfoto/Johnson & Johnson) NEW BRUNSWICK, N.J., March 12, 2021 /PRNewswire/ Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the World Health Organization (WHO) has issued Emergency Use Listing (EUL) for its single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), to prevent COVID-19 in individuals 18 years of age and older. Data from the Phase 3 ENSEMBLE study showed that the Johnson & Johnson COVID-19 vaccine was well tolerated and demonstrated a 67 percent reduction in symptomatic COVID-19 disease in participants who received the vaccine in comparison to participants given the placebo. The onset of protection was observed from day 14 and was maintained 28 days post-vaccination.

South africaUnited statesAlex gorskyPaul stoffelsPrnewswire johnsonMathai mammenProducts advisory committee onMelinda gates foundationAdvisory committeeJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonEuropean union onNone of the janssen pharmaceutical companiesWorld health organizationEuropean commissionUnited nations